top of page
  • ART-TG

ASMA is laureate of BPI "Grand Défi - Biomédicaments"

Updated: May 24, 2022

ART-TG is the industrial integrator for the ASMA project (Acoustic Solutions for Manufacturing Advanced Therapies) which is laureate of the "Grand Défi Biomédicaments" call for proposals that was launched by BPI in 2021. Led by Aenetis and regrouping 3 other partners (Yposkesi, CBM Orleans and ART-TG), ASMA aims to improve the production of gene therapy vectors and gene-modified cells with acoustic technologies.

Download PDF • 662KB

bottom of page